Projections of multi-morbidity in the older population in England to 2035: estimates from the Population Ageing and Care Simulation (PACSim) model
Top Cited Papers
Open Access
- 24 January 2018
- journal article
- research article
- Published by Oxford University Press (OUP) in Age and Ageing
- Vol. 47 (3), 374-380
- https://doi.org/10.1093/ageing/afx201
Abstract
Models projecting future disease burden have focussed on one or two diseases. Little is known on how risk factors of younger cohorts will play out in the future burden of multi-morbidity (two or more concurrent long-term conditions). a dynamic microsimulation model, the Population Ageing and Care Simulation (PACSim) model, simulates the characteristics (sociodemographic factors, health behaviours, chronic diseases and geriatric conditions) of individuals over the period 2014–2040. about 303,589 individuals aged 35 years and over (a 1% random sample of the 2014 England population) created from Understanding Society, the English Longitudinal Study of Ageing, and the Cognitive Function and Ageing Study II. the prevalence of, numbers with, and years lived with, chronic diseases, geriatric conditions and multi-morbidity. between 2015 and 2035, multi-morbidity prevalence is estimated to increase, the proportion with 4+ diseases almost doubling (2015:9.8%; 2035:17.0%) and two-thirds of those with 4+ diseases will have mental ill-health (dementia, depression, cognitive impairment no dementia). Multi-morbidity prevalence in incoming cohorts aged 65–74 years will rise (2015:45.7%; 2035:52.8%). Life expectancy gains (men 3.6 years, women: 2.9 years) will be spent mostly with 4+ diseases (men: 2.4 years, 65.9%; women: 2.5 years, 85.2%), resulting from increased prevalence of rather than longer survival with multi-morbidity. our findings indicate that over the next 20 years there will be an expansion of morbidity, particularly complex multi-morbidity (4+ diseases). We advocate for a new focus on prevention of, and appropriate and efficient service provision for those with, complex multi-morbidity.Funding Information
- Economic and Social Research Council (ESRC)
- National Institute for Health Research (NIHR) (ES/L001896/1)
- AXA Research Fund (2010-15)
- Centre of Excellence in Population Ageing Research (CEPAR) ((2014-2017))
This publication has 20 references indexed in Scilit:
- Forecasted trends in disability and life expectancy in England and Wales up to 2025: a modelling studyThe Lancet Public Health, 2017
- Associations between multimorbidity, healthcare utilisation and health status: evidence from 16 European countriesAge and Ageing, 2016
- The impact of multimorbidity on adult physical and mental health in low- and middle-income countries: what does the study on global ageing and adult health (SAGE) reveal?BMC Medicine, 2015
- Guidelines for people not for diseases: the challenges of applying UK clinical guidelines to people with multimorbidityAge and Ageing, 2012
- Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional studyThe Lancet, 2012
- Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalencePopulation Health Metrics, 2010
- Health and disease in 85 year olds: baseline findings from the Newcastle 85+ cohort studyBMJ, 2009
- The effect of dementia trends and treatments on longevity and disability: a simulation model based on the MRC Cognitive Function and Ageing Study (MRC CFAS)Age and Ageing, 2008
- Decomposition of differences in health expectancy by causeDemography, 2004
- Substantial potential for reductions in coronary heart disease mortality in the UK through changes in risk factor levelsJournal of Epidemiology and Community Health, 2003